Altimmune's SWOT analysis: pemvidutide potential drives stock outlook
Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...
Hosted on MSN39m
FDA releases update on chicken broth recall
The Food and Drug Administration (FDA) has released an update on a recall for chicken broth sold at Georgia Walmarts.